Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Goldan Keith A.
Chief Financial Officer at Syndax Pharmaceuticals. Filing since 13 Jun 2023.
CIK 0001495411
Company
Date
Role
Action
Shares
Amount
Of holding
SNDX
Syndax Pharmaceuticals Inc
1 Jun 2026
Chief Financial Officer
Sold at will
1,177
$22.35K
0.8%
SNDX
Syndax Pharmaceuticals Inc
9 Feb 2026
Chief Financial Officer
Sold at will
3,410
$71.71K
2.4%
SNDX
Syndax Pharmaceuticals Inc
6 Feb 2026
Chief Financial Officer
Sold at will
2,082
$42.93K
1.4%
SNDX
Syndax Pharmaceuticals Inc
16 Jul 2025
Chief Financial Officer
Sold at will
1,296
$12.03K
1.4%
SNDX
Syndax Pharmaceuticals Inc
19 May 2025
Chief Financial Officer
Bought
3,000
no price
3.3%
SNDX
Syndax Pharmaceuticals Inc
10 Feb 2025
Chief Financial Officer
Sold at will
3,777
$58.56K
4.0%
SNDX
Syndax Pharmaceuticals Inc
14 Jun 2024
Chief Financial Officer
Bought
1,250
$25.04K
2.4%
SNDX
Syndax Pharmaceuticals Inc
13 Jun 2023
Chief Financial Officer
Sold at will
577
$12.87K
18.0%
8 decisions on file.
